J. Goldman & CO LP Mereo Biopharma Group PLC Transaction History

J. Goldman & CO LP

$2.89 Billion
Q1 2024

A detailed history of J. Goldman & CO LP transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, J. Goldman & CO LP holds 278,588 shares of MREO stock, worth $1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

278,588

Previous 162,000 71.97%

Holding current value

$1 Million

Previous $374,000 145.72%

% of portfolio

0.03%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.3 - $4.05 $268,152 - $472,181	116,588 Added 71.97%	278,588 $919,000
Q4 2023 Feb 14, 2024	SELL	$1.19 - $2.42 $337,347 - $686,033	-283,485 Reduced 63.64%	162,000 $374,000
Q3 2023 Nov 14, 2023	BUY	$1.15 - $1.67 $108,674 - $157,815	94,500 Added 26.92%	445,485 $574,000
Q2 2023 Aug 14, 2023	SELL	$0.79 - $1.43 $202,646 - $366,816	-256,515 Reduced 42.22%	350,985 $463,000
Q1 2023 May 15, 2023	BUY	$0.71 - $1.22 $210,870 - $362,340	297,000 Added 95.65%	607,500 $431,000

Q3 2022 Nov 14, 2022	BUY	$0.84 - $1.73 $147,420 - $303,615	175,500 Added 130.0%	310,500 $267,000
Q2 2022 Aug 15, 2022	SELL	$0.33 - $1.69 $27,076 - $138,666	-82,051 Reduced 37.8%	135,000 $151,000
Q1 2022 May 16, 2022	BUY	$1.04 - $1.7 $155,532 - $254,235	149,550 Added 221.55%	217,051 $243,000
Q4 2021 Feb 14, 2022	SELL	$1.51 - $2.59 $262,607 - $450,432	-173,912 Reduced 72.04%	67,501 $108,000
Q3 2021 Nov 15, 2021	SELL	$2.2 - $3.17 $847,017 - $1.22 Million	-385,008 Reduced 61.46%	241,413 $584,000
Q2 2021 Aug 16, 2021	BUY	$2.94 - $4.08 $1.66 Million - $2.3 Million	563,654 Added 898.01%	626,421 $1.99 Million
Q1 2021 May 17, 2021	SELL	$2.6 - $4.43 $1.03 Million - $1.76 Million	-397,284 Reduced 86.36%	62,767 $212,000
Q4 2020 Feb 16, 2021	BUY	$1.95 - $3.6 $32,241 - $59,522	16,534 Added 3.73%	460,051 $1.65 Million
Q3 2020 Nov 16, 2020	BUY	$2.55 - $3.29 $1.13 Million - $1.46 Million	443,517 New	443,517 $1.16 Million

Others Institutions Holding MREO

# of Institutions

Shares Held

85.6M

Call Options Held

182K

Put Options Held

249K

View Full List

About Mereo Biopharma Group plc

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $450M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

More about MREO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Account